Research Calls
- Upgrades:
- Alliant Energy (LNT) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt lowered to $56
- Boston Beer Co (SAM) upgraded to Buy from Neutral at ROTH MKM; tgt raised to $386
- ChargePoint (CHPT) upgraded to Buy from Neutral at BofA Securities; tgt lowered to $14
- Coinbase Global (COIN) upgraded to Overweight from Neutral at Atlantic Equities; tgt $70
- Constellation Brands (STZ) upgraded to Buy from Neutral at ROTH MKM; tgt raised to $270
- * Elevation Oncology (ELEV) upgraded to Outperform from Market Perform at SVB Securities; tgt raised to $8
- Equitrans Midstream (ETRN) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $10
- Ford Motor (F) upgraded to Buy from Hold at Jefferies; tgt raised to $16
- HEICO (HEI) upgraded to Buy from Hold at Vertical Research; tgt $191
- Medtronic (MDT) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $104
- Paramount Global (PARA) upgraded to Peer Perform from Underperform at Wolfe Research
- Universal Health (UHS) upgraded to Outperform from Market Perform at SVB Securities; tgt raised to $170
- Downgrades:
- Abbott Labs (ABT) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt $112
- Millicom International Cellular (TIGO) downgraded to Equal Weight from Overweight at Barclays
- Others:
- ACELYRIN (SLRN) initiated with a Buy at Jefferies; tgt $31
- ACELYRIN (SLRN) initiated with an Overweight at Piper Sandler; tgt $68
- ACELYRIN (SLRN) initiated with an Outperform at TD Cowen
- Alcon (ALC) assumed with an Equal-Weight at Morgan Stanley; tgt $85
- Bausch + Lomb (BLCO) assumed with an Equal-Weight at Morgan Stanley; tgt $20
- Baxter (BAX) assumed with an Equal-Weight at Morgan Stanley; tgt $45
- Becton Dickinson (BDX) assumed with an Overweight at Morgan Stanley; tgt $295
- Boston Scientific (BSX) assumed with an Overweight at Morgan Stanley; tgt $58
- Confluent (CFLT) initiated with a Buy at Needham; tgt $35
- CRISPR Therapeutics (CRSP) initiated with an Outperform at William Blair; tgt $75
- Cooper (COO) initiated with an Equal-Weight at Morgan Stanley; tgt $410
- Dexcom (DXCM) assumed with an Equal-Weight at Morgan Stanley; tgt $131
- Edwards Lifesciences (EW) assumed with an Overweight at Morgan Stanley; tgt $102
- Insulet (PODD) assumed with an Equal-Weight at Morgan Stanley; tgt $343
- Johnson & Johnson (JNJ) resumed with a Buy at Citigroup; tgt $185
- Kenvue (KVUE) initiated with a Buy at BofA Securities; tgt $30
- Kenvue (KVUE) initiated with a Hold at Deutsche Bank; tgt $27
- Kenvue (KVUE) initiated with a Neutral at Citigroup; tgt $28
- Kenvue (KVUE) initiated with a Neutral at Exane BNP Paribas; tgt $28
- Kenvue (KVUE) initiated with a Neutral at Goldman; tgt $29
- Kenvue (KVUE) initiated with an Outperform at RBC Capital Mkts; tgt $29
- Kenvue (KVUE) initiated with an Overweight at JP Morgan; tgt $29
- Paylocity (PCTY) initiated with an Equal Weight at Barclays; tgt $199
- ShockWave Medical (SWAV) assumed with an Equal-Weight at Morgan Stanley; tgt $291
- Steris (STE) initiated with an Equal-Weight at Morgan Stanley; tgt $206
- Teleflex (TFX) assumed with an Equal-Weight at Morgan Stanley; tgt $261
- Vertex Pharma (VRTX) initiated with an Outperform at William Blair; tgt $382
- Viridian Therapeutics (VRDN) initiated with an Outperform at RBC Capital Mkts; tgt $44